BIOGEN INC. Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax
BIOGEN INC. (BIIB) reported Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax of $500.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-06.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax · last filed 2020-02-06
- BIOGEN INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2019 was $500.00K.
- BIOGEN INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2018 was -$27.30M, a 124.16% decline from fiscal 2017.
- BIOGEN INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2017 was $113.00M, a 126.91% increase from fiscal 2016.
- BIOGEN INC. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2016 was $49.80M, a 2666.67% increase from fiscal 2015.
| Period end | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 12 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 12 month as first filed |
|---|---|---|
| 2019-12-31 | $500.00K 10-K · filed 2020-02-06 | |
| 2018-12-31 | -$27.30M 10-K · filed 2020-02-06 | $27.30M 10-K · filed 2019-02-06 |
| 2017-12-31 | $113.00M 10-K · filed 2020-02-06 | |
| 2016-12-31 | $49.80M 10-K · filed 2019-02-06 | |
| 2015-12-31 | $1.80M 10-K · filed 2018-02-01 | |
| 2014-12-31 | $72.10M 10-K · filed 2017-02-02 | |
| 2013-12-31 | $23.60M 10-K · filed 2016-02-03 | -$23.60M 10-K · filed 2015-02-04 |
| 2012-12-31 | $11.80M 10-K · filed 2015-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |